Relay Therapeutics, Inc. RLAY
Set alert
17.84 USD +0.56 +3.24%
As of Nov 3, 1:44 PM ET
17.28 Day range 18.00
6.05 52-week range 20.75
- YTD
- +110.87%
- 1 year
- +157.06%
- Open
- 17.47
- Prev close
- 17.28
- Mkt cap
- 3.91B
- Vol
- 1.20M
- Avg vol
- 2.78M
- EPS
- -1.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.28
- High
- 18.00
- Forward P/E
- -10.59
- Beta
- 1.74
- Short ratio
- 13.49
- Inst. own
- 110.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 18.52
- 200-d avg
- 15.00
- 1y target
- 27.58
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.41; estimate -0.39107; surprise -4.84%
- Aug 7, 2026Rating: Barclays · Overweight → Overweight
- Aug 10, 2026Rating: Citizens · Market Outperform → Market Outperform
- Aug 14, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 20, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (24)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
Newest 20 of 24.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 27.58 +54.6% upside
Now 17.84
- Target (low)
- 20.00
- Target (mean)
- 27.58
- Target (high)
- 32.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy3
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40119 | -0.43 – -0.36 | -0.43 | +6.7% | 1.58M | 0.0% | 11 |
| Next quarter | -0.37949 | -0.46 – -0.29 | -0.31 | -22.4% | 7.77M | +11.0% | 11 |
| Current year | -1.61 | -1.72 – -1.47 | -1.61 | -0.2% | 11.19M | -27.2% | 11 |
| Next year | -1.63 | -1.83 – -1.11 | -1.61 | -1.1% | 17.91M | +60.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 16, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jul 8, 2026 | JP Morgan | Initiated | — | Overweight |
| May 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 26, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 20, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 20, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 19, 2026 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Apr 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 28, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 28, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 28, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Jones Trading | Initiated | — | Hold |
| Apr 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 17, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 17, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 26, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Dec 12, 2025 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Nov 7, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 26, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2025 | Raymond James | Maintained | Strong Buy | Strong Buy |
| May 7, 2025 | Guggenheim | Maintained | Buy | Buy |